The Sixth Cinven Fund, a fund managed by Cinven Limited entered into a definitive agreement to acquire BioClinica, Inc.

BioClinica, Inc. provides integrated clinical research technology solutions to pharmaceutical, biotechnology, medical device companies, and contract research organizations.